The Fosun Health Consumption Industry Group focuses on global strategic investment and in-depth industrial operations in the field of health products. It is committed to offering families around the world a safe, high-quality, and innovative platform for health products and services. This includes products and services in areas such as health foods, personal healthcare products, products for the elderly, consumer products for pets, and new retail sales.More
The Fosun Maternity and Family Industry Group focuses on its investments and corporate layout around the needs of mothers, babies, and the whole family. It is committed to offering families around the world, especially mothers and children, a safe, high-quality, innovative platform for products and services, including areas of innovation like maternity and baby consumer products, products targeted at young families, new retail, and related sectors.More
Health Insurance and Health Management Group is committed to becoming a provider of professional and comprehensive health insurance and health management services with a leading position in China and a global presence. As an extension of the Fosun Big Health Ecosystem, it has obtained all the licenses required for operating health insurance and insurance brokerage business and boasts global health management resources. With a focus on family customers, it provides integrated solutions for health management, medical services and protection against risks, aiming to become a health butler trusted by families around the world.More
Overseas Healthcare Service Group will establish a world-class healthcare service platform by enhancing the overseas healthcare service investment, merger and acquisition, operation, and post-investment management, providing innovation technology and solution in the developed countries and focusing on the investment of the fast-growing developing countries.More
RMB 33.1 Billion
Healthcare sector revenue in 2019
In the top 10 of the top 100 Chinese pharmaceutical enterprises in 2019
Approved beds of Fosun Pharma (4,238) and Luz Saude (1650) as of December 31, 2019
RMB 1.819 Billion
Fosun United Health Insurance achieved a premium revenue of more than RMB1.819 billion in 2019, representing a growth of around 249.79% as compared to the previous year. As a new and distinctive health insurance company, Fosun United Health Insurance endeavors to create a business ecosystem with digital and smart healthcare services.
The Group had 264 pipeline projects, including innovative drugs, generic drugs, biosimilars and consistency evaluation projects for generic drugs.
Efficient international R&D teams have been set up in China, the US, India, etc
*Source: Fosun International 2019 Annual Report and Fosun Pharma 2019 Annual Report